Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing.

Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML.

Antimicrob Agents Chemother. 2005 Jul;49(7):2612-7.

2.

Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms.

Pettit RK, Weber CA, Pettit GR.

Ann Clin Microbiol Antimicrob. 2009 Oct 27;8:28. doi: 10.1186/1476-0711-8-28.

3.

Microplate Alamar blue assay for susceptibility testing of Candida albicans biofilms.

Repp KK, Menor SA, Pettit RK.

Med Mycol. 2007 Nov;45(7):603-7.

PMID:
17885957
4.

High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.

Flemming K, Klingenberg C, Cavanagh JP, Sletteng M, Stensen W, Svendsen JS, Flaegstad T.

J Antimicrob Chemother. 2009 Jan;63(1):136-45. doi: 10.1093/jac/dkn464. Epub 2008 Nov 14.

PMID:
19010828
5.

Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry.

Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, Azeredo J.

J Antimicrob Chemother. 2005 Aug;56(2):331-6. Epub 2005 Jun 24.

6.

Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.

Claessens J, Roriz M, Merckx R, Baatsen P, Van Mellaert L, Van Eldere J.

Int J Antimicrob Agents. 2015 Apr;45(4):368-75. doi: 10.1016/j.ijantimicag.2014.11.011. Epub 2015 Jan 3.

PMID:
25614358
7.
8.

Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication.

Walencka E, Sadowska B, Rozalska S, Hryniewicz W, Rózalska B.

Pol J Microbiol. 2005;54(3):191-200.

PMID:
16450834
9.

Tolerance of Staphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents.

Khardori N, Yassien M, Wilson K.

J Ind Microbiol. 1995 Sep;15(3):148-51.

PMID:
8519470
10.

Confocal laser scanning microscopy analysis of S. epidermidis biofilms exposed to farnesol, vancomycin and rifampicin.

Cerca N, Gomes F, Pereira S, Teixeira P, Oliveira R.

BMC Res Notes. 2012 May 16;5:244. doi: 10.1186/1756-0500-5-244.

11.

In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods.

Baldoni D, Steinhuber A, Zimmerli W, Trampuz A.

Antimicrob Agents Chemother. 2010 Jan;54(1):157-63. doi: 10.1128/AAC.00700-09. Epub 2009 Oct 5.

12.

Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics.

Qu Y, Daley AJ, Istivan TS, Rouch DA, Deighton MA.

J Antimicrob Chemother. 2010 Jul;65(7):1405-11. doi: 10.1093/jac/dkq119. Epub 2010 Apr 29.

PMID:
20430788
13.

Effect of cinnamon oil on icaA expression and biofilm formation by Staphylococcus epidermidis.

Nuryastuti T, van der Mei HC, Busscher HJ, Iravati S, Aman AT, Krom BP.

Appl Environ Microbiol. 2009 Nov;75(21):6850-5. doi: 10.1128/AEM.00875-09. Epub 2009 Sep 11.

14.

Minimal attachment killing (MAK): a versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis.

Knobloch JK, Von Osten H, Horstkotte MA, Rohde H, Mack D.

Med Microbiol Immunol. 2002 Oct;191(2):107-14. Epub 2002 Jun 29.

PMID:
12410350
15.

Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.

Domínguez-Herrera J, Docobo-Pérez F, López-Rojas R, Pichardo C, Ruiz-Valderas R, Lepe JA, Pachón J.

Antimicrob Agents Chemother. 2012 Feb;56(2):613-7. doi: 10.1128/AAC.05606-11. Epub 2011 Nov 28.

17.

Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms.

Yang S, Hay ID, Cameron DR, Speir M, Cui B, Su F, Peleg AY, Lithgow T, Deighton MA, Qu Y.

Sci Rep. 2015 Dec 21;5:18578. doi: 10.1038/srep18578.

18.

Biofilm formation is not necessary for development of quinolone-resistant "persister" cells in an attached Staphylococcus epidermidis population.

Knobloch JK, Von Osten H, Horstkotte MA, Rohde H, Mack D.

Int J Artif Organs. 2008 Sep;31(9):752-60.

PMID:
18924086
19.

The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.

Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A.

J Clin Microbiol. 1999 Jun;37(6):1771-6.

20.

Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis.

Peck KR, Kim SW, Jung SI, Kim YS, Oh WS, Lee JY, Jin JH, Kim S, Song JH, Kobayashi H.

Chemotherapy. 2003 Jul;49(4):189-93.

PMID:
12886054

Supplemental Content

Support Center